Uncertainty and validation of health economic decision models
Authors:
- 10 February 2009
- journal article
- research article
- Published by Wiley in Health Economics
- Vol. 19 (1) , 43-55
Abstract
Health economic decision models are based on specific assumptions relating to model structure and parameter estimation. Validation of these models is recommended as an indicator of reliability, but is not commonly reported. Furthermore, models derived from different data and employing different assumptions may produce a variety of results.A Markov model for evaluating the long‐term cost‐effectiveness of screening for abdominal aortic aneurysm is described. Internal, prospective and external validations are carried out using individual participant data from two randomised trials. Validation is assessed in terms of total numbers and timings of key events, and total costs and life‐years. Since the initial model validates well only internally, two further models are developed that better fit the prospective and external validation data. All three models are then extrapolated to a life‐time horizon, producing cost‐effectiveness estimates ranging from £1600 to £4200 per life‐year gained.Parameter uncertainty is now commonly addressed in health economic decision modelling. However, the derivation of models from different data sources adds another level of uncertainty. This extra uncertainty should be recognised in practical decision‐making and, where possible, specifically investigated through independent model validation. Copyright © 2009 John Wiley & Sons, Ltd.Keywords
This publication has 25 references indexed in Scilit:
- Cost-effectiveness analyses alongside randomised clinical trialsClinical Trials, 2006
- Whither trial‐based economic evaluation for health care decision making?Health Economics, 2006
- Comparing Model Structures in Cost-Effectiveness AnalysisMedical Decision Making, 2005
- Multiparameter Evidence Synthesis in Epidemiology and Medical Decision-Making: Current ApproachesJournal of the Royal Statistical Society Series A: Statistics in Society, 2005
- Probabilistic Analysis of Cost-Effectiveness Models: Statistical Representation of Parameter UncertaintyValue in Health, 2005
- Validation of the CORE Diabetes Model Against Epidemiological and Clinical StudiesCurrent Medical Research and Opinion, 2004
- Alternative decision modelling techniques for the evaluation of health care technologies: Markov processes versus discrete event simulationHealth Economics, 2002
- Multicentre aneurysm screening study (MASS): cost effectiveness analysis of screening for abdominal aortic aneurysms based on four year results from randomised controlled trialBMJ, 2002
- Systematic validation of disease models for pharmacoeconomic evaluationsJournal of Evaluation in Clinical Practice, 1999
- Growth rates and risk of rupture of abdominal aortic aneurysmsBritish Journal of Surgery, 1998